Mark Elliott Boulding Ptc Therapeutics, Inc. (PTCT) insider trading activity

Mark Elliott Boulding is EXEC. VP AND CLO of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 92,389 shares of PTCT, which is worth approximately $4.18 Million. The most recent transaction as insider was on Feb 10, 2022, when has been sold 17,935 shares (Common Stock) at a price of $45.03 per share, resulting in proceeds of $807,613. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92.4K

0% 3M change

22.57% 12M change

Total Value Held $4.18 Million

Mark Elliott Boulding Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 10 2022	SELL Open market or private sale	$807,613 $45.03 p/Share	17,935 Reduced 22.69%	61,110 Common Stock
Feb 10 2022	BUY Exercise of conversion of derivative security	$262,210 $14.62 p/Share	17,935 Added 18.94%	76,763 Common Stock
Feb 01 2022	SELL Open market or private sale	$31,160 $40.0 p/Share	779 Reduced 1.26%	61,110 Common Stock
Jan 07 2022	SELL Open market or private sale	$34,090 $38.52 p/Share	885 Reduced 1.83%	47,489 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	14,400 Added 18.88%	61,889 Common Stock
Sep 02 2021	SELL Open market or private sale	$151,369 $45.01 p/Share	3,363 Reduced 6.5%	48,374 Common Stock
Sep 02 2021	BUY Exercise of conversion of derivative security	$60,568 $18.01 p/Share	3,363 Added 6.1%	51,737 Common Stock
Jul 09 2021	SELL Open market or private sale	$64,305 $45.0 p/Share	1,429 Reduced 2.87%	48,374 Common Stock
Jul 09 2021	BUY Exercise of conversion of derivative security	$25,736 $18.01 p/Share	1,429 Added 2.86%	48,618 Common Stock
Jul 08 2021	SELL Open market or private sale	$353,020 $45.23 p/Share	7,805 Reduced 13.89%	48,374 Common Stock
Jul 08 2021	BUY Exercise of conversion of derivative security	$122,929 $15.75 p/Share	7,805 Added 13.55%	49,779 Common Stock
Feb 01 2021	SELL Open market or private sale	$44,315 $56.96 p/Share	778 Reduced 1.58%	48,374 Common Stock
Jan 06 2021	BUY Grant, award, or other acquisition	-	10,200 Added 17.19%	49,152 Common Stock
Jan 05 2021	SELL Open market or private sale	$48,150 $62.37 p/Share	772 Reduced 1.94%	38,952 Common Stock

MEB

Mark Elliott Boulding

EXEC. VP AND CLO

South Plainfield, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Value

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT

Account